EISAI LIMITED - GB 

Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 1
As coordinator: 0
As participant: 1
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2016 0 8.838.000 0 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ABBVIE DEUTSCHLAND GMBH & CO KG1
ARTTIC1
ASTRAZENECA AB1
AXXAM1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV1
ELI LILLY AND COMPANY LIMITED1
F HOFFMANNLA ROCHE1
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V1
GOETEBORGS UNIVERSITET1
H LUNDBECK AS1
JANSSEN PHARMACEUTICA NV1
KING'S COLLEGE LONDON1
LIFE AND BRAIN1
ORION OYJ1
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT1
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE1
UNIVERSITATSKLINIKUM BONN1
UNIVERSITY COLLEGE LONDON1

Constancy:

Total number of partners: 19
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 19
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2016-11-01Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976 PHAGOparticipant8.838.00020